Camp4 Therapeutics (CAMP) Shares Outstanding (2023 - 2026)

Camp4 Therapeutics has reported Shares Outstanding (Entity) for 4 years, with the latest figure at $51.9 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 157.55% year-over-year to $51.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.9 million (up 157.55% YoY) and the FY2025 annual result came in at $30.4 million, up 547.76% from the prior year.
• Shares Outstanding (Entity) advanced to $51.9 million in Q1 2026 per CAMP's latest filing, from $30.4 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $51.9 million in Q1 2026 and troughed at $394976.0 in Q4 2023.
• A 4-year average of $14.3 million and a median of $4.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) soared 36.71% in 2024, then soared 4792.88% in 2025.
• Over 4 years, Shares Outstanding (Entity) stood at $394976.0 in 2023, then surged by 1087.44% to $4.7 million in 2024, then soared by 547.76% to $30.4 million in 2025, then soared by 70.92% to $51.9 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $51.9 million, $30.4 million, and $27.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.